The purpose of this study is to determine whether a combined behavioral and pharmacological intervention provided by a multidisciplinary team will further reduce LDL-C, smoking, BP and Hb-A1C in diabetic patients with A1c between 7% and 9% when compared to usual care.

Inclusion Criteria:

• Previous enrollment in Cardiovascular Risk Reduction Clinic (CRRC)

• Eligible for CRRC discharge:

  1. For DM patients:

     • HbA1c < 7.0 %,
     • BP < 130/85 mm Hg , and
     • LDL < 100 mg/dl;

  2. For Non-DM patients:

     • BP < 140/90 mm Hg, and
     • LDL < 100 mg/dl;

• Able and willing to sign informed consent.

Exclusion Criteria:

• Presence of conditions that might limit long-term compliance (eg, dementia, acute psychiatric decompensation within the previous 6 months, unstable psychiatric disorder);
• Metastatic disease or terminal illness